ABSTRACT -Omeprazole (OPZ), a proton pump inhibitor, is a cytochrome P450 (CYP) 1A1/2 inducer. Some CYP1A inducers are known to have liver tumor promoting effects in rats and the ability to enhance oxidative stress. In this study, we performed a two-stage liver carcinogenesis bioassay in rats to examine the tumor promoting effect of OPZ (Experiment 1) and to clarify a possible mechanism of action (Experiment 2). In Experiment 1, male F344 rats were subjected to a two-third partial hepatectomy, and treated with 0, 138 or 276 mg/kg OPZ by oral gavage once a day for six weeks after an intraperitoneal injection of N-diethylnitrosamine (DEN). Liver weights significantly increased in the DEN+OPZ groups, and the number and area of glutathione S-transferase placental form (GST-P) positive foci significantly increased in the DEN+276 mg/kg OPZ group. In Experiment 2, the same experiment as Experiment 1 was performed, but the dosage of OPZ was 0 or 276 mg/kg. The number and area of GST-P positive foci as well as liver weights significantly increased in the DEN+276 mg/kg OPZ group. The number of proliferative cell nuclear antigen (PCNA)-positive cells also significantly increased in the same group. Real-time RT-PCR showed that the expression of AhR battery genes including Cyp1a1, Cyp1a2, Ugt1a6 and Nqo1, and Nrf2 battery genes including Gpx2, Yc2, Akr7a3, Aldh1a1 Me1 and Ggt1 were significantly upregulated in this group. However, the production of microsomal reactive oxygen species (ROS) and formation of thiobarbituric acid-reactive substances (TBARS) decreased, and 8-hydroxydeoxyguanosine (8-OHdG) content remained unchanged in this group. These results indicate that OPZ, CYP1A inducer, is a liver tumor promoter in rats, but oxidative stress is not involved in the liver tumor promoting effect of OPZ.
INTRODUCTION
Omeprazole (OPZ) is a proton pump (H + , K + -ATPase) inhibitor characterized by a benzimidazole structure that is widely used as a blocker of gastric acid secretion in gastric parietal cells (Ma and Lu, 2007) . As a result of its efficacy, OPZ is used clinically in humans for the treatment of dyspepsia, peptic ulcer, gastro-esophageal reflux disease, and the Zollinger-Ellison syndrome (Ma and Lu, 2007) . In addition, it has been reported that OPZ has an anti-proliferation effect in pancreatic cancer cell line (Udelnow et al., 2011) . On the other hand, oncogenicity studies have found that OPZ may induce gastric carcinoids in rats, but not in mice (Ekman et al., 1985) , with the finding that hyperplasia of oxyntic mucosal cells (including hyperplasia of endocrine ECL-cells and development of gastric carcinoids in rats) can be attributed to the hypergastrinemia produced as a secondary effect of inhibition of acid secretion by the large doses of OPZ used (Ekaman et al., 1985) . It has also been reported that OPZ can induce cytochrome P450 (CYP) 1A1/2 expression in human hepatocytes in vivo and in vitro (Diaz et al., 1990) .
Both the CYP1A1 and CYP1A2 enzymes can be induced by a range of chemicals in a process mediated through the aryl hydrocarbon receptor (AhR) (Ma and Lu, 2007) . AhR then heterodimerizes with the AhR nuclear translocator and the heterodimer binds to the cis-ele-ment called xenobiotic responsive element located in the promoter region of target genes to activate their transcription (Yoshinari et al., 2008) . The 'classical' AhR ligands are potent activators and include the halogenated aromatic hydrocarbons like 2,3,7,8-tetrachloro-dibenzo-dioxin (TCDD) and polyaromatic hydrocarbons such as 3-methylcholanthrene and polychlorinated biphenyls (PCBs), and β-naphthoflavone (BNF) (Coe et al., 2006) . In contrast, several compounds known as atypical CYP1A inducers induce CYP1A without direct binding to the AhR (Lemaire et al, 2004) , including benzimidazole compounds such as oxfendazole (OX) and indole-3-carcinol (I3C) (Coe et al., 2006; Gleizes-Escala et al., 1996; Lesca et al., 1995) . Another benzimidazole compound, OPZ is also known to induce AhR; however, the molecular mechanism underlying this process is not yet clear.
Some CYP1A inducers such as TCDD and BNF are known to have liver tumor promoting effects in rats and the ability to augment oxidative stress (Kociba et al., 1987; Dewa et al., 2008) . It is generally accepted that microsomal electron system including CYPs and NADPH-cytochrome P450 reductase generates reactive oxygen species (ROS) via metabolism, with the subsequent formation of an oxygenated substrate and water (Poulos and Raag, 1992) . Although electron transfer is normally a well-coupled process, superoxide and H 2 O 2 may be released in the presence of CYP1A inducers that are poorly metabolized. In contrast, atypical CYP1A inducers such as OX and I3C also have hepatocellular tumor promoting activities (Dewa et al., 2009; Shimamoto et al., 2011a) , and promote hepatocellular tumors via oxidative stress. In long-term carcinogenicity studies of OPZ, hepatocarcinogenicity in rats given OPZ for 2 years was not found, but treatment with 138 mg/kg OPZ induced hepatocellular hyperplastic nodules in the liver of female rats (Ekman et al., 1985) . In addition, oral administration of 100 mg/kg OPZ for 14 successive days to rats which had previously been treated with N-diethylnitrosamine (DEN) led to a significant increase in the number of gamma-glutamyltranspeptidase (Ggt) positive foci in the liver (Mereto et al., 1993) .
In the present study, we have performed a two-stage liver carcinogenesis bioassay in rats to examine the tumor-promoting effects of OPZ in the liver and to clarify the possible mechanism of OPZ, with a particular focus on gene expression and biochemical events of ROS generation, 8-hydroxydeoxyguanosine (8-OHdG) and thiobarbituric acid-reactive substances (TBARS) production in the liver.
MATERIALS AND METHODS

Chemicals
OPZ and DEN (CAS No. 55-18-5) were purchased from Wako Pure Chemical Industries (Osaka, Japan) and Tokyo Kasei Kogyo (Tokyo, Japan) with purities of 98% and 99%, respectively.
Animals
Five-week-old male F344 rats in Experiments 1 and 2 were purchased from Japan SLC, Inc. (Shizuoka, Japan), maintained in an air-conditioned room with a twelve-hour light/dark cycle (room temperature, 23°C ± 3°C; relative humidity, 55 ± 15%), and given free access to a basal diet (Oriental MF; Oriental Yeast, Tokyo, Japan) and tap water. After a one-week acclimatization period, the animals were used in the experiments. The animals received human care in accordance with the Guide for Animal Experimentation of the Tokyo University of Agriculture and Technology.
Experimental designs Experiment 1
A medium-term liver carcinogenesis bioassay (Ito et al., 2003) was performed according to the following procedure to examine the liver tumor promoting effect of OPZ: First, all rats were treated with an intraperitoneal injection of DEN at a dose of 200 mg/kg body weight, followed by treatment with 0 (DEN alone), 138 or 276 mg/kg OPZ by oral gavage once a day for six weeks starting two weeks after DEN treatment. In the previous study, since 138 mg/kg OPZ induced hepatocellular hyperplastic nodules in the liver of female rats in a long-term carcinogenicity study (Ekman et al., 1985) , we adopted this dose as the low dose in the present study. In our previous pilot study (Data not shown), we conducted a 2-week repeated oral dose study of OPZ at doses of 0, 37.5, 75 or 150 mg/kg body weight/day in rats and confirmed that the expression of Phase I enzyme genes such as Cyp1a1 inducing ROS generation and phase II enzyme genes to eliminate the ROS produced such as Yc2, Gpx2, Akr7a3 and Nqo1 were up-regulated in the rats treated with OPZ. The expression of these genes was up-regulated in a dose-dependent manner. Therefore, we did not set the untreated and OPZ alone groups in the present study. To enhance hepatocellular proliferation, the rats were subjected to two-third partial hepatectomy at 1 week after the OPZ treatment was started. In the first two weeks, the body weight was measured once a week, and then measured every three days during the promotion period, and the OPZ dose was then determined based on these data.
At the end of the experiment, the rats were euthanized by exsanguination while under ether anesthesia and their livers were excised and weighed. The sliced liver samples were fixed in either 10% phosphate-buffered formalin for histopathological and immunohistochemical evaluations.
Experiment 2
The analysis of Experiment 1 revealed that 276 mg/kg OPZ had a liver tumor promoting activity. Therefore, we performed an additional experiment to clarify the possible mechanism of OPZ, with a particular focus on the oxidative stress. All rats were handled and treated in the same manner as in Experiment 1. In brief, two weeks after DEN treatment, the rats were administered 0 (DEN alone) or 276 mg/kg OPZ by oral gavage once a day for six weeks. In the first two weeks, the body weight was measured once a week, and then measured every three days during the promotion period, and the OPZ dose was then determined based on these data. At the end of the experiment, the rats were euthanized by exsanguination while under ether anesthesia and their livers were excised and weighed. The sliced liver samples were fixed in either 10% phosphate-buffered formalin for histopathological and immunohistochemical evaluations or were frozen in liquid nitrogen and stored at -80°C until further analysis.
Histopathology and immunohistochemistry
After formalin fixation of livers in Experiments 1 and 2, the tissues were dehydrated in graded ethanol and embedded in paraffin. Sections were then mounted onto the glass slides and stained with hematoxylin and eosin (H&E) or they were used for immunohistochemistry analysis. For immunohistochemistry, the horseradish peroxidase avidin-biotin complex method with a Vectastain Elite ABC kit (Vector Laboratories Burlingame, CA, USA) was used. Endogenous peroxidase was inhibited by incubation with freshly prepared 0.3% hydrogen peroxide with methanol for 30 min. The sections were incubated overnight with rabbit polyclonal anti-glutathione S-transferase placental form (GST-P) antibody (Medical & Biological Laboratories, Nagoya, Japan; 1:1000) and mouse monoclonal anti-proliferative cell nuclear antigen PCNA antibody (DAKO, Glostrup, Denmark; 1:800) at 4°C, followed by incubation with a biotinylated secondary antibody for 30 min and with avidin peroxidase conjugate for 30 min at room temperature. The sections were then developed in 0.05% 3, 3'-diaminobenzidine/hydrogen peroxide as the chromogen. For PCNA staining, the deparaffinized tissue sections were placed in an antigen-retrieval solution (0.01 M citrate buffer, pH 6.0) for 20 min in a hot bath at 60°C prior to immunohistochemical staining. After staining, the slides were lightly counterstained with hematoxylin.
The numbers and areas of GST-P positive foci (≥ 0.2 mm in diameter) and total areas of the liver sections were quantified using WinRoof software (v5.7.2; Mitani Corp., Fukui, Japan). The number of PCNA positive cells counted under 200 × magnification was expressed as a percentage of total cells counted in 20 randomly selected fields. In both analyses, cranial and caudal parts of the right lateral liver lobe were used.
cDNA microarray analysis
Total RNA of the liver obtained from Experiment 2 was extracted with an RNeasy Mini Kit (QIAGEN, Hilden, Germany), in accordance with the manufacturer's instructions. Using 10 μg of total RNA from one animal from each of the control and 276 mg/kg OPZ groups, doublestranded cDNA was synthesized with the Invitrogen Superscript Double-Stranded cDNA Synthesis kit (Invitrogen Corp., Carlsbad, CA, USA), in accordance with the manufacturer's protocol. After labeling with the Cy3, 6 μg of each of the Cy3-labeled cDNA sample were loaded onto the Rattus norvegicus Roche NimbleGen microarray for Gene Expression (Roche NimbleGen: Euk Expr 385K catalog Arr, 26,739 targets/microarray). Using Robust Multiple Average normalization method (Irizarry et al., 2003) , differentially expressed genes were analyzed. Gene information was retrieved from the National Center for Biotechnology information (http://www.ncbi. nlm.nih.gov) website.
Real-time RT-PCR analysis
Total RNA of the liver obtained from Experiment 2 was extracted with an RNeasy Mini Kit (QIAGEN), in accordance with the manufacturer's instructions. Reverse transcription was carried out with 2 μg RNA for cDNA synthesis using a Thermoscript RT-PCR System kit (Eppendorf Co., Ltd., Tokyo, Japan) in accordance with the manufacturer's protocol. Quantitative real-time RT-PCR with Power SYBR Green PCR Master Mix (Applied Biosystems Japan Ltd., Tokyo, Japan) was performed using a StepOnePlus™ Real-time PCR System (Applied Biosystems Japan Ltd.). The PCR primers (listed in Table 1) were designed using Primer Express software (Version 3.0; Applied Biosystems Japan Ltd.). The amount of target gene expression was normalized to an endogenous reference (Actin, beta) and relative to control was obtained using 2 -ΔΔCt method (Livak and Schmittgen, 2001 ).
Lipid peroxidation levels
Oxidative lipid peroxidation was estimated using TBARS. Hepatic TBARS levels were determined using the method described by Ohkawa et al. (1979) with a slight modification. The liver tissue samples (approximately 50 mg) obtained from Experiment 2 were homogenized in 450 μl of buffer (containing 50 mM TrisHCl; pH7.4, 1.15% KCl, 0.2 mM EDTA, 0.1 mM DTT, 0.1 mM Protease Inhibitor Cocktail and 20% glycerol) using TissueLyser (QIAGEN). Aliquots of 3.0 mg of liver homogenates were mixed with 0.2 ml of 8.1% sodium dodecyl sulfate and 3.0 ml of 0.4% thiobarbituric acid in 10% acetic acid (pH 3.5), heated at 95°C for 60 min and then cooled. Each reaction mixture was centrifuged at 4000 rpm for 10 min after adding 1.0 ml of distilled water and 5.0 ml n-butanol and pyridine (15:1, v/v). The absorbance of the resulting solution was determined spectrophotometrically at 532 nm, using a Synergy HT Multi-Detection Microplate Reader (BioTek, Winooski, VT, USA). The TBARS levels were expressed as the equivalents of malondialdehyde (MDA) amounts that were produced from 1,1,3,3,-tetramethoxypropane.
Preparation of microsomal fraction
The microsomal fractions were obtained according to the methods described by Yoshihara et al. (2001) . The liver tissue samples (approximately 100 to 130 mg) obtained from Experiment 2 were homogenized in 700 μl of ice-cold buffer (containing 50 mM Tris-HCl; pH7.4, 1.15% KCl, 0.2 mM ethylene diamine tetra-acetic acid, 0.1 mM DTT, 0.1 mM Protease Inhibitor Cocktail and 20% glycerol) using a pestle. The homogenate was centrifuged at 700 × g for 10 min at 4°C, and supernatant was centrifuged at 10,000 × g for 20 min at 4°C. The 500 μl of supernatant was ultracentrifuged at 105,000 × g for 90 min. The microsomal pellet was resuspended in the microsome buffer, and protein content of the homogenate was measured using the BCA Protein Assay Kit (Pierce, IL, USA) with BSA as a standard.
Microsomal reactive oxygen species production
NADPH-dependent microsomal ROS production was determined by measuring the oxidation of 2',7'-dichlorodihydrofluorescein diacetate (H 2 DCFDA) to its fluorescent product 2',7'-dichlorofluorescein (DCF) in liver microsomes according to the methods described by Schlezinger et al. (1999) . The microsomes (final concentration 0.2 mg/ml) obtained from Experiment 2 were incubated in the dark at 37°C for 30 min in 50 mM TrisHCl (pH 7.4) and 5 μM H 2 DCFDA. In addition, 2.5 mM β-NADPH was added. In some cases, 0.1 mM SKF-525A (Toronto Research Chemicals, ON, Canada), a wellknown inhibitor of cytochrome P450, and 0.1 mM H 2 O 2 as a positive control were added to the wells. The fluorescence was monitored every 5 minutes over 2 hr using a Synergy HT Multi-Detection Microplate Reader (BioTek) with excitation and emission wavelengths of 485 and 528 nm, respectively. The data were then normalized to the control values, with the control expressed as a value of 100%. Oxidative DNA damage levels Oxidative DNA damage in the liver was estimated as 8-OHdG. The 8-OHdG levels in liver DNA was determined using the method of Umemura et al. (2006) . Briefly, nuclear DNA obtained from Experiment 2 was isolated from 0.3 g of a wet weight sample, using a DNA Extractor WB Kit (Wako Pure Chemical Industries) containing an antioxidant NaI solution to dissolve the cellular components. For further prevention of autooxidation in the cell-lysis step, deferoxamine mesylate was added to the lysis buffer (Helbock et al., 1998) . The DNA was digested into deoxynucleotides with nuclease P1 and alkaline phosphatase. The levels of 8-OHdG (8-OHdG/10 5 deoxyguanosine) were then assessed by high-performance liquid chromatography with an electrochemical detection system (Coulochem II; ESA Biosciences, Inc., Chelmstord, MA, USA) using previously reported running conditions (Umemura et al., 2006) .
Statistical analysis
All data were expressed as mean plus standard deviation. Numerical data were evaluated using the following methods: In Experiment 1, a Bartlett's test for equal variance was used to determine if the variance was homogenous between the groups. If the variance was homogenous, numerical data were assessed using Dunnett's multiple test. If a significant difference in variance was observed, Steel test was used instead. In Experiment 2, an F test for equal variance was used to determine if the variance was homogenous between the groups. If the variance was homogenous, numerical data were assessed using a t test. If a significant difference in variance was observed, the Welch's t test was used instead.
RESULTS
Experiment 1 Body and liver weights and food intake (Experiment 1)
In OPZ treated groups, the body weight was significantly lower than that of the DEN control group from 6 weeks after the start of experiment and the final body weight was significantly lower than that in the DEN control group (Table 2) . Food intakes were not changed during the study period in the OPZ treated groups. The absolute and relative liver weights significantly increased in the OPZ treated groups compared to the DEN control group.
Histopathological examinations and GST-P positive foci in the liver (Experiment 1)
Histopathological analysis revealed centrilobular hypertrophy of hepatocytes, and foci of cellular alterations consisting of clear, eosinophilic and basophilic cells were induced in the OPZ treated groups given 138 and 276 mg/kg. Immunohistochemical analysis revealed that the number and area of GST-P positive foci significantly increased in the 276 mg/kg OPZ group compared with the DEN control group (Fig. 1, Table 2 ).
Experiment 2 Body and liver weights and food intake (Experiment 2)
In the DEN+ 276 mg/kg OPZ group, the body weight gain was lower than that of the DEN control group from 3 weeks after the start of experiment and the final body weight was significantly lower than the DEN control group (Table 3) . Food intakes were not changed dur- ing the study period between the groups. The absolute and relative liver weights significantly increased in the DEN+OPZ group, being approximately 1.3-fold higher than those of the DEN control group.
Histopathological examinations and GST-P positive foci in the liver
Histopathological analysis revealed an increased number of foci of cellular alterations consisting of clear, eosinophilic and basophilic cells in the DEN+OPZ group. Immunohistochemical analysis revealed that the number and area of GST-P-positive foci significantly increased in the DEN+OPZ group (Table 3) . Moreover, the number of PCNA-positive cells also significantly increased in the DEN+OPZ group (Table 3) .
DNA microarray and real-time RT-PCR analyses (Experiment 2)
Hepatic gene expression changes in rats treated with OPZ were screened using an oligonucleotide microarray. In the microarray, 177 or 251 genes showed more than a two-fold increase or more than a half-fold decrease, respectively, in their expression in one OPZ-treatment rat as compared with a rat of the DEN control group (supplementary data). Where gene expression was upregulated, we focused on the AhR battery and oxidative stress response-related genes. Real-time RT-PCR analysis on the genes listed in Table 1 was performed using liver samples (6 rats/group), except for the genes for Cyp1a1 (11 rats/control group and 12 rats/OPZ group) (Table 4 ). In the AhR gene battery, a significant increase in the gene expression of Cyp1a1, Cyp1a2, Nqo1, Ugt1a6 was observed in the DEN+OPZ group. In addition, antioxidant and/or detoxifying genes against oxidative stress such as Gpx2, Yc2, Akr7a3, Aldh1a1, Me1 and Ggt1 significantly increased in the DEN+OPZ group as compared with the DEN control group.
Microsomal ROS production (Experiment 2)
To estimate the cellular sources of ROS, NADPHdependent ROS production was measured in liver microsomes (Table 5 ). The oxidized indicator was not detected in the absence of NADPH. By the addition of NADPH into the microsomal system, ROS production was dramatically enhanced, but ROS production in the DEN+OPZ group was less than that of the DEN control group. A well-known inhibitor of P450, SKF-525A, inhibited NADPH-dependent ROS production.
Oxidative stress on cellular membrane and DNA (Experiment 2)
To evaluate whether the oxidative damages to the cellular components occur, 8-OHdG content and TBARS formation were determined in the liver (Table 5 ). The content of 8-OHdG was not significantly changed in rats treated with OPZ as compared with that of the DEN control group. By contrast, TBARS content in the DEN+OPZ group was less than that of the DEN control group.
DISCUSSION
In a two-year carcinogenicity study of OPZ in rats, no significant increase in the incidence of liver tumors was found. In contrast, in that study where female rats were treated orally with 138 mg/kg OPZ, it was found that this treatment regimen induced hepatocellular hyperplastic nodules in the liver (Ekman et al., 1985) . The term hepatocellular hyperplastic nodule is often used to describe non-neoplastic proliferative lesions in the liver of rodents which can be induced by repeated administration of certain chemicals causing degeneration and necrosis of hepatocytes (Maronpot et al., 1986) . In addition, a significant increase in the number of Ggt-positive foci was observed in the liver of rats subjected to oral administration of 100 mg/kg OPZ for 14 successive days after DEN treatment, further suggesting that OPZ treatment may confer greater susceptibility to tumorigenic changes (Mereto et al., 1993) . In Experiment 1 of the present study, the number and area of GST-P positive foci significantly increased in rats given 276 mg/kg OPZ after DEN treatment. To confirm the reproducibility of increased GST-P positive foci in OPZ treated groups of Experiment 1, we performed an additional experiment, Experiment 2. In Experiment 2, the number and area of GST-P positive foci also increased in the 276 mg/kg OPZ group. Additionally, the number of PCNA (a well-known cell proliferating marker) positive cells (Naryzhny, 2008 ) also increased in the DEN+OPZ group compared with the DEN control group. Since the medium-term liver carcinogenesis bioassay used in these studies has been repeatedly validated for the detection of hepatocarcinogens because of its high efficacy and very low false-positive rates (Ito et al., 2003) , these results from our study strongly indicate that OPZ has a liver tumor promoting effect in rats.
The genes Cyp1a1/2, Nqo1 and Ugt1a6 are well characterized as belonging to an 'AhR gene battery' (Köhle and Bock, 2007; Schrenk, 1998; Nebert et al., 2000) . In the present study, these genes significantly increased in the DEN+276 mg/kg OPZ group compared with the DEN control group, suggesting that OPZ activates AhR and induces upregulation of this AhR gene battery. Although CYP1A1 is expressed at low levels in extra-hepatic tissues in humans, it is significantly induced in the liver and extra-hepatic tissues by a range of chemicals (Ma and Lu, 2007) . In comparison, CYP1A2 is constitutively expressed in the human liver, but is further induced by AhR agonists (Köhle and Bock, 2007) . NQO1 detoxifies quinones by two-electron reduction to quinols without generating reactive semiqunines (Köhle and Bock, 2007) and UGT1A6 is a UDP-glycosyltransferase and conjugates a variety of planar phenols (Köhle and Bock, 2007) . It is generally known that the cytochrome P-450 family generates ROS as byproducts of microsomal oxidation. CYP1A1 is a reactive CYP and generates a very large amount of ROS (Puntarulo and Cederbaum, 1998) . It has been reported that the production of ROS due to increased CYP1A expression is induced not only by classical AhR ligands but also the atypical, non-AhR ligand such as OX (Dewa et al., 2009) . PCB also increases CYP1A1-dependent microsomal ROS production in the liver of rats (Schlezinger et al., 2006) . Therefore, upregulation of these genes suggest that ROS are generated in the microsome following treatment with OPZ.
Furthermore, the antioxidative genes regulated by Nrf2 such as Gpx2, Yc2, Akr7a3, Aldh1a1, Me1 and Ggt1 also significantly increased in the DEN+OPZ group. Nrf2, which is a transcriptional factor, regulates the expression of genes encoding the phase II detoxifying enzymes by binding to the antioxidant responsive elements (Itoh et al., 1997) , and is activated by oxidative/electrophile stress (Köhle and Bock, 2007) . GPX2 is a member of the glutathione peroxidase (GPX) family and reduces H 2 O 2 (Naiki- Ito et al., 2007) . GSTs including Yc2 detoxify xenobiotics by conjugating glutathione to a range of electrophilic substrates (Thimmulappa et al., 2002) . AKR7A3 is a NADPH-dependent oxido-reductase and catalyzes the reduction of aldehyde and keto groups (Thimmulappa et al., 2002) . ALDH1A1 has a substrate preference for the aldehyde products of lipid peroxidation such as malondialdehyde (Alnouti and Klaassen, 2008) . ME1 is a NADPH generating enzyme, and increased induction of Me1 may be useful to the antioxidant effect (Thimmulappa et al., 2002) . GGT1 has an antioxidant effect and is involved in the metabolism of glutathione (Ravuri et al., 2011) . Upregulation of these genes suggests that the ROS produced following treatment of OPZ was probably eliminated as a result of the action of the genes found within this Nrf2 gene battery. In other words, OPZ induces microsomal ROS by the induction of AhR, and ROS production was probably attenuated by the induction of these xenobiotic metabolizing enzymes. Since ROS production was predicted in the liver of rats given DEN+OPZ based on the upregulation of AhR and Nrf2 gene batteries, we therefore measured the oxidative stress markers including microsomal ROS, TBARS and 8-OHdG. However, microsomal ROS production and TBARS formation decreased in the DEN+276 mg/kg OPZ group compared with the DEN control group. In addition, 8-OHdG content remained unchanged in this group. These findings suggest that microsomal ROS generation, lipid peroxidation and DNA oxidative stress were not enhanced by the treatment of OPZ, in spite of the fact that the antioxidant genes were upregulated in the DEN+OPZ group. This means that the content of the ROS generation was not enough to induce lipid peroxidation and DNA oxidative stress. The plasma concentration of OPZ reached its peak (T max ) at 40.6 min, and then decreased to half levels after 24 min in male Sprague-Dawley rats given a single oral administration of OPZ (Lee et al., 2007) . Taking into account the rapid metabolism of OPZ, and given that the animals were subjected to oral OPZ dosing once a day in the present study, it can be speculated that ROS generation in the liver increases transiently, but most of the ROS produced are then eliminated by antioxidant enzymes. Therefore, the results obtained in the present study suggest that microsomal ROS is not directly involved in the liver tumor promotion mechanism of OPZ in rats, but we should clarify the more precise mechanism of the tumor promoting effect of OPZ in the future studies.
So far, we have demonstrated that several CYP1A inducers, including OX, BNF, piperonyl butoxide, and I3C, have liver tumor promoting activities in a two-stage hepatocarcinogenesis model in rats (Muguruma et al., 2007; Shoda et al., 2000; Dewa et al., 2008; Shimamoto et al., 2011b) . These chemicals induce ROS generation in the microsomal fractions, and this ROS generation is suspected of enhancing liver tumor promotion by altering cellular physiological functions, such as oxidative proteins, lipid peroxidation, DNA damage and cell signaling (Muguruma et al., 2007; Dewa et al., 2008; Nishimura et al., 2010; Shimamoto et al., 2011a) . Therefore, we speculated that most of the CYP1A inducers may have ROSmediated liver tumor promoting activities in rats. However, we must reconsider our hypothesis, taking into account the finding of the present study that microsomal ROS is not involved in the liver tumor promotion of OPZ in rats.
Since OPZ is used for the treatment of dyspepsia, peptic ulcer, gastro-esophageal reflux disease, and the Zollinger-Ellison syndrome, we must pay an attention of the human risk of OPZ's tumor promoting effect. As the clinical dose recommended by the US Food and Drug Administraion (Howden, 1991; McTavish et al., 1991) , the therapeutic dose in human is 20 mg/day that is equivalent to 0.33 mg/kg body weight/day. On the other hand, in the present study, the DEN initiated rats were given 276 mg/kg OPZ. Therefore, this dose inducing the liver tumor promoting effect in rats is 828 times higher than the daily exposure dose of OPZ in human. This means that the human risk in the liver tumor promotion is extremely low when patients receive the OPZ's treatment.
In conclusion, we have confirmed that OPZ, CYP1A inducer, has a liver tumor promoting effect in rats, but the present study suggests that oxidative stress does not play a pivotal role in the liver tumor promotion of OPZ and further studies are necessary to clarify the precise mechanism of action.
